These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21636146)

  • 21. Stent thrombosis--risk assessment and prevention.
    Motovska Z; Knot J; Widimsky P
    Cardiovasc Ther; 2010 Oct; 28(5):e92-100. PubMed ID: 20553282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) SELECT substudy.
    Patti G; Chello M; Pasceri V; Colonna D; Colonna G; Pepe LL; Montinaro A; Covino E; Di Sciascio G
    J Cardiovasc Med (Hagerstown); 2011 Mar; 12(3):151-6. PubMed ID: 21085001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stent thrombosis and drug-eluting stents.
    Takayama T; Hiro T; Hirayama A
    J Cardiol; 2011 Sep; 58(2):92-8. PubMed ID: 21839615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of bisoprolol dose on ADP-induced platelet aggregability in patients on dual antiplatelet therapy.
    Ignjatovic VS; Petrovic N; Miloradovic V; Ignjatovic S; Cokanovic V; Grdinic A; Simic I; Petrovic I; Nikolic S; Andjelkovic A; Paramentic D; Ignjatovic S
    Coron Artery Dis; 2010 Dec; 21(8):472-6. PubMed ID: 20861734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epistaxis as the reason for premature discontinuation of clopidogrel after percutaneous coronary angioplasty with stent implantation.
    Jura-Szołtys E; Chudek J
    Kardiol Pol; 2011; 69(8):817-23. PubMed ID: 21850627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is stent thrombosis the new Achilles heel of interventional cardiology? State of the Art clinical trials, causes and approaches for prevention].
    Grumann T; Diehl P; Bode C; Moser M
    Hamostaseologie; 2007 Dec; 27(5):344-50. PubMed ID: 18060244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
    Bhatt SH; Hauser TH
    Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stent thrombosis.
    Holmes DR; Kereiakes DJ; Garg S; Serruys PW; Dehmer GJ; Ellis SG; Williams DO; Kimura T; Moliterno DJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1357-65. PubMed ID: 20946992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.
    Murray AT; Sederberg JH
    Semin Cardiothorac Vasc Anesth; 2011; 15(1-2):40-3. PubMed ID: 21840879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clopidogrel withdrawal: is there a "rebound" phenomenon?
    Sambu N; Warner T; Curzen N
    Thromb Haemost; 2011 Feb; 105(2):211-20. PubMed ID: 21103667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The GRAVITAS study].
    Rollini F; Angiolillo DJ; Cattaneo M
    G Ital Cardiol (Rome); 2012 Jan; 13(1):1-5. PubMed ID: 22322466
    [No Abstract]   [Full Text] [Related]  

  • 32. Tirofiban use with clopidogrel and aspirin decreases adverse cardiovascular events after percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.
    Sethi A; Bahekar A; Doshi H; Bhuriya R; Bedi U; Singh S; Khosla S
    Can J Cardiol; 2011; 27(5):548-54. PubMed ID: 21871775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
    Tan VP; Yan BP; Kiernan TJ; Ajani AE
    Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversation with an expert. Plavix: what you need to know.
    O'Gara P
    Harv Heart Lett; 2011 Jan; 21(5):3. PubMed ID: 21322911
    [No Abstract]   [Full Text] [Related]  

  • 35. Competing pharmacological strategies during PCI-analysis of a prematurely terminated trial.
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):1010-1. PubMed ID: 21598352
    [No Abstract]   [Full Text] [Related]  

  • 36. [Warfarin combined with blood platelet inhibition].
    Vik-Mo H
    Tidsskr Nor Laegeforen; 2011 Feb; 131(3):252-3. PubMed ID: 21304575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stent thrombosis in 2008: definition, predictors, prognosis and treatment.
    Lemesle G; Delhaye C; Bonello L; de Labriolle A; Waksman R; Pichard A
    Arch Cardiovasc Dis; 2008; 101(11-12):769-77. PubMed ID: 19059572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary antithrombotic strategies in patients undergoing coronary stent implantation.
    Bartorelli AL; Trabattoni D
    Minerva Cardioangiol; 2002 Oct; 50(5):517-30. PubMed ID: 12384634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.
    Mohammad RA; Goldberg T; Dorsch MP; Cheng JW
    Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.